With only five available drugs approved by the U.S. FDA to treat Alzheimer's disease, the National Institute on Aging has awarded a $6.1 million grant to the UArizona Center for Innovation in Brain Science to investigate a novel approach to treat the disease. The center is led by a top neuroscientist and BIO5 member, Dr. Roberta Diaz Brinton.
Related
